HDAC/IKK inhibition therapies in solid tumors
Oncotarget
.
2017 May 23;8(21):34030-34031.
doi: 10.18632/oncotarget.17512.
Authors
Ivana Vancurova
1
,
Himavanth R Gatla
1
,
Ales Vancura
1
Affiliation
1
Department of Biological Sciences, St. John's University, NY, USA.
PMID:
28504965
PMCID:
PMC5470948
DOI:
10.18632/oncotarget.17512
No abstract available
Keywords:
HDAC; IL-8/CXCL8; IκB kinase; ovarian cancer; solid tumors.
Publication types
Editorial
Grants and funding
R15 CA202775/CA/NCI NIH HHS/United States